SpiroChem
Anna Wozniak is an experienced finance professional with a strong background in strategic and financial leadership. Anna serves as the Chief Financial Officer at SpiroChem and has held key roles such as Associate Partner at FS Partners - The CFO Company and Chief Financial and Development Officer at Castor. Previously, Anna worked at BC Platforms as EVP of Strategy and Development and CFO, and at Syngenta as a Finance Business Partner across multiple global divisions. Anna's academic credentials include a Master's in Management with a focus on Finance & Strategy from ESCP Business School and advanced studies in Capital Markets at the University of St.Gallen.
This person is not in any offices
SpiroChem
SpiroChem is an Elite Discovery Chemistry Contract Research Organization (CRO) working with clients worldwide from biotechs, pharmaceutical, agrochemical, and life science companies of all sizes. Our company, operating in Basel, Switzerland, offers unique and innovative solutions covering the entire discovery chemistry value chain: - Proprietary Screening Libraries including high-sp3 fragments, covalent fragments and macrocycles - SpiroKit as turnkey toolboxes for the medicinal chemistry community to speed up research programs - Design & Computational Team for fragment-based drug design (FBDD), structure-based drug design (SBDD) and computational-aided drug design (CADD) - Medicinal Chemistry group including experts in enabling technologies (photochemistry, photoredox, electrochemistry, biocatalysis, …) to access target molecule faster and explore uncharted chemical space - An Early Development division involved in Route Scouting projects to make the bridge between the medicinal chemistry lab and CDMOs - Thanks to two-high potent labs, SpiroChem also supports discovery in the field of ADCs (linker-payload chemistry)